Skip to main content

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Minutes of Proceedings

45th Parliament, 1st Session
Meeting 30
Thursday, April 23, 2026, 3:30 p.m. to 6:42 p.m.
Webcast
Presiding
Hon. Hedy Fry, Chair (Liberal)

Library of Parliament
• Antoine Dedewanou, Analyst
• Kelly Farrah, Analyst
• Tu-Quynh Trinh, Analyst
BioCanRx
• Stéphanie Michaud, President and Chief Executive Officer
Canadian Association for Pharmacy Distribution Management
• Angelique Berg, President and Chief Executive Officer
• Simona Zar, Senior Vice-President, Government Relations
Diabetes Canada
• Glenn Thibeault, Executive Director, Government Affairs, Advocacy and Policy
HealthPRO Canada
• Christine Donaldson, President and Chief Executive Officer
Neighbourhood Pharmacy Association of Canada
• Sandra Hanna, Chief Executive Officer
VaxSynergy
• Denis Leclerc, Director and Full Professor, CHU de Québec, Université Laval
Pursuant to Standing Order 108(2) and the motion adopted by the committee on Tuesday, September 23, 2025, the committee resumed its study of Canada’s pharmaceutical sovereignty.

Glenn Thibeault, Christine Donaldson and Denis Leclerc made statements and answered questions.

At 4:34 p.m., the meeting was suspended.

At 4:43 p.m., the meeting resumed.

Stéphanie Michaud, Angelique Berg and Sandra Hanna made statements and answered questions.

Motion

Dan Mazier moved, — That the committee resume debate on a motion that was move on Tuesday, April 21, 2026.

The question was put on the motion and it was agreed to on the following recorded division:

YEAS: Burton Bailey, Maxime Blanchette-Joncas, Helena Konanz, Dan Mazier, Matt Strauss — 5;

NAYS: Maggie Chi, Peter Fragiskatos, Helena Jaczek, Sonia Sidhu — 4.

At 5:21 p.m., the meeting was suspended.

At 5:24 p.m., the meeting resumed.

The committee resumed consideration of the motion of Dan Mazier moved on Tuesday, April 21, 2026, which read as follows:

That the committee order the production of the following documents, unredacted, for the period from 2016 to the present:

  1. Contribution agreements concluded with Canada Health Infoway relating to PrescribeIT.
  2. A record of the intellectual property developed under PrescribeIT, including the entity that holds the rights and the general terms of use, licensing, or transfer.
  3. Annual adoption data, broken down by province.
  4. The total revenue generated from the $ 0.20 per-prescription fee.
  5. Viability analyses and program evaluations.
  6. Documents that led to the decision to terminate the program, including recommendations and analyses provided to Health Canada and to the Minister, where applicable.
  7. A list of the principal vendors involved in the program, including amounts paid to each.
  8. Documents and analyses related to the costs of terminating the program, including contractual obligations, penalties, and transition costs.

That these documents be provided by Health Canada and Canada Health Infoway, in accordance with their respective responsibilities, and deposited with the Clerk of the Committee within one week of the adoption of this motion.

That any redactions be limited to commercially confidential information and that a summary of redacted content and the reasons for such redactions be provided.

Maggie Chi raised a point of order as to the disruption of the order of the day and agenda of the committee.

Another point of order was raised as per the nature of her intervention in relation to the Standing Orders.

RULING BY THE CHAIR

The chair ruled the intervention of Maggie Chi in order as related to the order of the day.

Whereupon, Dan Mazier appealed the decision of the Chair.

The question: “Shall the decision of the Chair be sustained?” was put and the decision was overturned on the following recorded division:

YEAS: Burton Bailey, Helena Konanz, Dan Mazier, Matt Strauss, Maxime Blanchette-Joncas — 5;

NAYS: Maggie Chi, Peter Fragiskatos, Helena Jaczek, Sonia Sidhu — 4.

Debate resumed on the motion of Dan Mazier.

At 6:03 p.m., the meeting was suspended.

At 6:22 p.m., the meeting resumed.

Debate resumed on the motion of Dan Mazier.

On motion of Maggie Chi, it was agreed, — That the committee do now adjourn..

At 6:42 p.m., the committee adjourned to the call of the Chair.



Catherine Ngando Edimo
Clerk of the committee